Skip to main content
Equibles

HighTower Advisors, LLC

Position in ZYME — Zymeworks Inc.

CIK 1462245 CHICAGO, IL
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$943,654
+$35,654 QoQ
Shares Held
36,100
-0.4% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 202 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. ZYME ranks #31 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in ZYME

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $943,654 36,100
2026-03-31 $908,000 36,262